Web Based Investigation of Natural History of Keloid Disorder, an Online Survey
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01423981|
Recruitment Status : Recruiting
First Posted : August 26, 2011
Last Update Posted : October 4, 2016
|Condition or disease|
This will be a web based study, whereby patients will have to read and acknowledge the consent form online. Once patients agree and acknowledge the terms of the consent form, they will gain access to the questionnaire pages.
For those who are under age of 18, a parent or a legal guardian must sign the consent form and answer the online questions on behalf of the patient.
|Study Type :||Observational|
|Estimated Enrollment :||10000 participants|
|Official Title:||Web Based Investigation of Natural History of Keloid Disorder, an Online Survey|
|Study Start Date :||November 2011|
|Estimated Primary Completion Date :||December 2030|
|Estimated Study Completion Date :||June 2031|
Patients with keloid disorder.
All participants have a clinical diagnosis of keloid.
- Determine the prevalence different phenotypes of keloid in participants. [ Time Frame: Two years ]Prevalence of different phenotypes of keloid will be measured in the study population and reported. Prevalence of familial keloid in the study population will also be determined and reported. Data will be analyzed to determine the distribution of keloid among different ethic groups. Data will be analyzed to report the percentage of patients who have had one or more treatments and the percentage of patients who have had successful treatments.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01423981
|Contact: Michael H Tirgan, MD||(212) 874 email@example.com|
|United States, New York|
|Michael H. Tirgan, MD||Recruiting|
|New York, New York, United States, 10023|
|Contact: Michael H Tirgan, MD 212-874-4200 firstname.lastname@example.org|
|Principal Investigator: Michael H Tirgan, MD|
|Principal Investigator:||Michael H Tirgan, MD||Keloid Research Foundation|